Milestone Scientific Cash Flow from Investing Activities 2010-2024 | MLSS

Milestone Scientific cash flow from investing activities from 2010 to 2024. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
Milestone Scientific Annual Cash Flow Investing
(Millions of US $)
2023 $-3
2022 $-0
2021 $-0
2020 $-0
2019 $-0
2018 $-0
2017 $-0
2016 $0
2015 $-4
2014 $-1
2013 $-1
2012 $-0
2011 $-0
2010 $-0
2009 $-0
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.053B $0.010B
Milestone Scientific, Inc. develops, manufactures, markets and sells equipment and related disposable or consumable items and other products for use primarily by the dental practitioner. The company's principal product is ``The Wand(TM)``, a computer controlled ``painless`` injection system enabling the practitioner to more quickly and effectively anesthetize patients in certain dental applications. The company also markets and sells: ``SplatrFree(TM)`` disposable prophy angles and related consumable products; and clinically oriented dental products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $73.379B 20.59
Becton Dickinson (BDX) United States $68.292B 19.32
West Pharmaceutical Services (WST) United States $25.906B 46.43
Cardinal Health (CAH) United States $24.133B 13.80
Align Technology (ALGN) United States $20.439B 39.46
Cooper (COO) United States $19.341B 29.27
Labcorp (LH) United States $17.753B 15.28
Henry Schein (HSIC) United States $9.553B 16.99
DENTSPLY SIRONA (XRAY) United States $5.872B 15.20
Merit Medical Systems (MMSI) United States $4.758B 26.08
Patterson (PDCO) United States $2.308B 11.06
CONMED (CNMD) United States $2.301B 20.87
STAAR Surgical (STAA) United States $2.098B 80.57
Atrion (ATRI) United States $0.819B 43.73
Lifevantage (LFVN) United States $0.086B 11.11
Pro-Dex (PDEX) United States $0.067B 33.62
Biolase (BIOL) United States $0.005B 0.00